1. Home
  2. GOAI vs ONCY Comparison

GOAI vs ONCY Comparison

Compare GOAI & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eva Live Inc. Common Stock

GOAI

Eva Live Inc. Common Stock

N/A

Current Price

$1.66

Market Cap

89.9M

Sector

Technology

ML Signal

N/A

Logo Oncolytics Biotech Inc.

ONCY

Oncolytics Biotech Inc.

HOLD

Current Price

$0.84

Market Cap

92.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GOAI
ONCY
Founded
2015
1998
Country
United States
Canada
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Pharmaceuticals and Biotechnology
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
89.9M
92.5M
IPO Year
2023
2002

Fundamental Metrics

Financial Performance
Metric
GOAI
ONCY
Price
$1.66
$0.84
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$7.33
AVG Volume (30 Days)
195.5K
893.9K
Earning Date
04-10-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
966.67
N/A
EPS
N/A
N/A
Revenue
$17,037,328.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$2,505.00
P/E Ratio
N/A
N/A
Revenue Growth
82.59
N/A
52 Week Low
$1.42
$0.73
52 Week High
$6.67
$1.51

Technical Indicators

Market Signals
Indicator
GOAI
ONCY
Relative Strength Index (RSI) 30.63 50.41
Support Level N/A $0.78
Resistance Level $2.68 $1.08
Average True Range (ATR) 0.16 0.04
MACD 0.01 0.01
Stochastic Oscillator 37.10 88.44

Price Performance

Historical Comparison
GOAI
ONCY

About GOAI Eva Live Inc. Common Stock

Eva Live Inc is a United States-based technology company that has developed an automated and intelligent advertiser campaign management platform, Eva Platform, which enables advertisers ('customers, clients') to buy advertising space on several digital channels to reach their desired audience. The company also works with Businesses that utilize its in-house digital marketing capabilities, including advice, creative services, account management, production of advertising materials, media planning, and buying.

About ONCY Oncolytics Biotech Inc.

Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer, among others.

Share on Social Networks: